2023 Was a tough yr for that biopharma marketplace, with various firms downsizing and restructuring their workforces to remain afloat. There are signs of recovery, as mergers and acquisitions picked up through the pharmaceutical and daily life sciences marketplace inside the latter Element of 2023 and have continued their upswing https://sites.google.com/view/bio-sites/blog